Cargando…

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome

SIMPLE SUMMARY: Immunosurveillance of cancer is mediated by T cell-based recognition of tumor-associated antigens, i.e., short peptides that are presented on the surface of cells on human leukocyte antigen (HLA) molecules. This encourages the analysis of the entirety of HLA-presented peptides, the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marconato, Maddalena, Maringer, Yacine, Walz, Juliane S., Nelde, Annika, Heitmann, Jonas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563800/ https://www.ncbi.nlm.nih.gov/pubmed/36230581 http://dx.doi.org/10.3390/cancers14194659

Ejemplares similares

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021)

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
por: Hackenbruch, Christopher, et al.
Publicado: (2023)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
por: Wacker, Marcel, et al.
Publicado: (2023)

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
por: Tegeler, Christian M., et al.
Publicado: (2022)

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
por: Nelde, Annika, et al.
Publicado: (2022)

Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
por: Seller, Anna, et al.
Publicado: (2023)

TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification
por: Hoenisch Gravel, Naomi, et al.
Publicado: (2023)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
por: Maringer, Yacine, et al.
Publicado: (2022)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Roerden, Malte, et al.
Publicado: (2020)

Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia
por: Tandler, Claudia, et al.
Publicado: (2020)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
por: Heitmann, Jonas S., et al.
Publicado: (2021)

Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia
por: Marconato, Maddalena, et al.
Publicado: (2022)

The Peptide Vaccine of the Future
por: Nelde, Annika, et al.
Publicado: (2021)

The immunopeptidomic landscape of ovarian carcinomas
por: Schuster, Heiko, et al.
Publicado: (2017)

Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
por: Narayan, Rupa, et al.
Publicado: (2019)

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
por: Marcu, Ana, et al.
Publicado: (2021)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
por: Kaban, Kübra, et al.
Publicado: (2021)

Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Admon, Arie
Publicado: (2021)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
por: ElAbd, Hesham, et al.
Publicado: (2021)

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
por: Heitmann, Jonas S., et al.
Publicado: (2023)

SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function
por: Brunk, Fabian, et al.
Publicado: (2021)

Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia
por: Märklin, Melanie, et al.
Publicado: (2020)

DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
por: Chashchina, Anna, et al.
Publicado: (2021)

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
por: Bauer, Jens, et al.
Publicado: (2022)

The Impact of Biomaterial Cell Contact on the Immunopeptidome
por: Ghosh, Michael, et al.
Publicado: (2020)

Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Mishto, Michele
Publicado: (2021)

Mining the Immunopeptidome for Antigenic Peptides in Cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2022)

Unraveling the glycosylated immunopeptidome with HLA-Glyco
por: Bedran, Georges, et al.
Publicado: (2023)

The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies
por: Becker, Jonas P., et al.
Publicado: (2022)

CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022)

An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib
por: Haddad, Fady Gh, et al.
Publicado: (2021)

New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing
por: Doménech, Elena, et al.
Publicado: (2012)

Constitutive and Inflammatory Immunopeptidome of Pancreatic β-Cells
por: Dudek, Nadine L., et al.
Publicado: (2012)

Murine xenograft bioreactors for human immunopeptidome discovery
por: Heather, James M., et al.
Publicado: (2019)

caAtlas: An immunopeptidome atlas of human cancer
por: Yi, Xinpei, et al.
Publicado: (2021)

Leveraging Immunopeptidomics To Study and Combat Infectious Disease
por: Leddy, Owen K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1nsfq4gonkgl4q839njbn21qr0